Decision Resources Group Acquires Context Matters to Expand Global Market Access Intelligence Offerings

BURLINGTON, Mass., Aug. 16, 2017 /PRNewswire/ -- Decision Resources Group (DRG), the life sciences industry's most trusted provider of market intelligence and global data products and services, today announced that it has completed the acquisition of Context Matters, the innovative data technology start-up that developed a first-of-its-kind global market access integrated data platform. Previously the lead investor in a Series B funding round for the startup last fall, DRG's full acquisition and planned integration of Context Matters cements its position as the partner of choice for global market access data products, analytics, and strategic guidance.

The acquisition of Context Matters reinforces DRG's commitment to providing a deep understanding of global market access landscapes which life sciences organizations can leverage to drive profitable asset management from development through commercialization. It will fortify DRG's global market access portfolio by combining the novel Context Matters data model, which links global regulatory and health technology assessment data to detailed clinical trial data, with DRG's existing suite of products and services.  The addition of Context Matters will result in a full service global market access and drug value navigation partner to the life sciences industry, with the flexibility to deliver solutions scaled to client needs and timing—from tactical target points to end-to-end enterprise strategy.

"There is an ever-rising demand to optimize global access to treatments for patients in therapy areas that continue to have unmet need. In our increasingly complex and cost-benefit driven markets, it is imperative for healthcare companies to build robust, evidence-based approaches to plan and prepare their assets for successful global market access," says Peter Hempshall, Senior Vice President of DRG. "With the acquisition of Context Matters, DRG is pleased to welcome an experienced team of pioneering global market access experts. They have been at the forefront of compiling and connecting disparate forms of data to provide life sciences companies with the depth of data and direction needed to plan and implement successful access, reimbursement and asset valuation strategies for varied global markets."

"Context Matters was created from the idea that data from market access and reimbursement can be used to inform clinical trial design," explained Yin Ho, M.D., M.B.A., the Founder and CEO of Context Matters. "It has been extremely gratifying to watch Context Matters become a force to change the thinking of the pharmaceutical industry around how to use data to position and honestly evaluate the value of customers' assets in a global marketplace," said Dr. Ho. "We have been leaders in the industry and our vision will continue to live on in our products, services, and customers as we move forward with DRG."

About Context Matters, Inc.

Context Matters modernizes and improves the process of valuing drug therapies, empowering life sciences organizations to achieve optimal reimbursement for their innovation. The Context Matters Market Access Platform (MAP) defines a new product category for global drug valuation—a configurable technology platform linking drug development and market data through a sophisticated model making comparative analysis and contextual views possible to establish reimbursement and market access. The MAP is a disruptive innovation that provides pharmaceutical and biotechnology companies direct access to the insights they need to inform key product development decisions and gain optimal reimbursement value. Visit ContextMatters.com for more information.

About Decision Resources Group

Decision Resources Group, a subsidiary of Piramal Enterprises Ltd., is the premier source for global healthcare data and market intelligence. A trusted partner for over 20 years, DRG helps companies competing in the global healthcare industry make informed business decisions. Organizations committed to the development and delivery of life-changing therapies rely on DRG's in-house team of expert healthcare analysts, data scientists, and consultants for critical guidance. DRG products and services, built on extensive data assets and delivered by experts, empower organizations to succeed in complex healthcare markets. Please visit decisionresourcesgroup.com for more information.

For press inquiries, please contact Tori Gillern at [email protected].

SOURCE Decision Resources Group

Related Links

http://www.decisionresourcesgroup.com